论文部分内容阅读
多数抗肿瘤药物可以引起后不同程度的骨髓抑制，这往往是被迫减量或停药的最常见原因。本文报告59例患者应用重组人粒细胞集落刺激因子（rhG－CSF）治疗化疗后引起外周血粒细胞减少的临床观察结果，以探讨rhG－CSF在恶性肿瘤化疗中的合理应用。1病例资料和方法59例中，男35例，
Most anti-cancer drugs can cause various degrees of myelosuppression, which is often the most common cause of forced reduction or discontinuation. This article reports the clinical observation results of 59 patients with recombinant human granulocyte colony-stimulating factor (rhG-CSF) treatment of chemotherapy induced peripheral blood granulocyte reduction, in order to explore the reasonable application of rhG-CSF in malignant tumor chemotherapy. 1Case information and methods of 59 cases, 35 males,